Combination of Lenalidomide and Autologous Mature Dendritic Cells Pulsed With KRN7000 in Myeloma

NCT00698776 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Myeloma

Interventions

DRUG: Lenalidomide
BIOLOGICAL: Monocyte derived DCs loaded with KRN7000

Sponsor

Yale University

Collaborators

[object Object]
[object Object]